Science Applications International Corporation SAIC R3KTECHAI
Company Overview
Science Applications International Corporation provides technical, engineering, and mission and enterprise information technology (IT) services in the United States. It operates through two segments, Defense and Intelligence; and Civilian. The company offers IT modernization services for defense, intelligence, and civilian agencies; digital engineering services; artificial intelligence (AI) solutions; mission systems support and advisory; training and simulation; and ground vehicle support services for the nation's armed forces. It also provides services for the design, development, integration, deployment, management and operations, sustainability, and security of IT infrastructure; mission IT solutions comprising CJADC2, data and AI, digital transformation, and quantum technologies; enterprise IT solutions consisting of service management, cloud, cybersecurity, and digital workplace; engineering services, including system integration and delivery services; and professional services, such as program management. The company serves military forces, including the Army, Air Force, Navy, Marines, Coast Guard, and Space Force; agencies of the Department of War, National Aeronautics and Space Administration, U.S. Department of State, Department of Justice, and Department of Homeland Security; and members of the Intelligence Community, as well as civilian markets, such as federal, state, and local governments. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.
Why Investors Should Care
Generates a return on equity of 25.7%, reflecting efficient use of shareholder capital.
Trades at a P/E of 14.9, below the sector median of 29.2.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jan 2026 Revenue of $7.26B (-2.9% YoY); net profit $358.00M.
- Trailing 12 Months Year-on-year growth — revenue +6.3%, earnings -12.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.9%, profit CAGR 4.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.90% |
| 1 Year: | 6.30% |
Compounded Profit Growth
| 5 Years: | 4.61% |
| 1 Year: | -12.20% |
Stock Price Performance
| 1 Year: | +7.28% |
| 6 Months: | +36.22% |
| 3 Months: | +13.04% |
| 1 Month: | +0.80% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.81 · Neutral
P/E of 14.87 is below the sector median of 29.22 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 25.7%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SAIC Science Applications International Corporation R3KTECHAI | 127.55 | 14.87 | $5.34B | 1.11% | 11.92% | 25.74% | 2.90% | 4.61% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | May 2016 | Aug 2016 | Nov 2016 | Feb 2017 | May 2017 | Aug 2017 | Nov 2017 | Feb 2018 | May 2018 | Aug 2018 | Nov 2018 | Feb 2019 | May 2019 | Aug 2019 | Nov 2019 | Jan 2020 | May 2020 | Jul 2020 | Oct 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | May 2023 | Aug 2023 | Nov 2023 | May 2024 | Aug 2024 | Nov 2024 | Jan 2025 | Apr 2025 | May 2025 | Jul 2025 | Aug 2025 | Oct 2025 | Jan 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 1.10B | 1.08B | 1.15B | 1.13B | 1.18B | 1.11B | 1.18B | 1.19B | 1.61B | 1.59B | 1.63B | 1.54B | 1.76B | 1.76B | 1.82B | 1.88B | 1.84B | 1.90B | 2.00B | 1.83B | 1.91B | 2.03B | 1.78B | 1.90B | 1.85B | 1.82B | 1.98B | - | 1.88B | 1.88B | 1.77B | 1.77B | 1.87B | 1.75B | 1.91B | 1.91B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.67B | - | 1.55B | - | 1.64B | 1.53B | 1.66B | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 209.00M | - | 215.00M | - | 227.00M | 221.00M | 249.00M | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 88.00M | - | 76.00M | - | 99.00M | 88.00M | 70.00M | - |
| Operating Income | 64.00M | 68.00M | 72.00M | 59.00M | 63.00M | 59.00M | 72.00M | 62.00M | 66.00M | 74.00M | 73.00M | 7.00M | 93.00M | 95.00M | 94.00M | 88.00M | 78.00M | 100.00M | 110.00M | 130.00M | 133.00M | 114.00M | 125.00M | 125.00M | 133.00M | 157.00M | 362.00M | 143.00M | 131.00M | 134.00M | 160.00M | - | 121.00M | 121.00M | 139.00M | 139.00M | 128.00M | 133.00M | 179.00M | 179.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 152.00M | - | 174.00M | - | 165.00M | 173.00M | 218.00M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.00M | - | 31.00M | - | 33.00M | 34.00M | 33.00M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 86.00M | - | 108.00M | - | 94.00M | 99.00M | 145.00M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.00M | - | -19.00M | - | 16.00M | 14.00M | 30.00M | - |
| Net Income | 31.00M | 36.00M | 41.00M | 35.00M | 49.00M | 36.00M | 43.00M | 51.00M | 49.00M | 49.00M | 48.00M | -9.00M | 55.00M | 57.00M | 55.00M | 60.00M | 36.00M | 51.00M | 60.00M | 81.00M | 82.00M | 71.00M | 73.00M | 73.00M | 80.00M | 98.00M | 247.00M | 93.00M | 77.00M | 81.00M | 106.00M | - | 68.00M | 68.00M | 127.00M | 127.00M | 78.00M | 85.00M | 115.00M | 115.00M |
| Diluted EPS | 0.67 | 0.78 | 0.90 | 0.77 | 1.08 | 0.80 | 0.98 | 1.16 | 1.13 | 1.13 | 1.11 | -0.20 | 0.92 | 0.96 | 0.94 | 1.01 | 0.62 | 0.87 | 1.02 | 1.38 | 1.41 | 1.22 | 1.29 | 1.30 | 1.45 | 1.79 | 4.56 | 1.76 | 1.48 | 1.58 | 2.13 | - | 1.42 | 1.42 | 2.71 | 2.71 | 1.69 | 1.87 | 2.61 | 2.61 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Feb 2023 | Jan 2024 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.73B | 4.78B | 4.12B | 3.88B | 4.32B | 4.44B | 4.45B | 4.66B | 6.38B | 7.06B | - | 7.70B | 7.70B | 7.44B | 7.44B | 7.48B | 7.26B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | 6.82B | - | 6.57B | - | 6.59B | 6.39B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | 888.00M | - | 872.00M | - | 892.00M | 872.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | 374.00M | - | 371.00M | - | 329.00M | 351.00M |
| Operating Income | 299.00M | 281.00M | 183.00M | 240.00M | 227.00M | 263.00M | 256.00M | 220.00M | 370.00M | 390.00M | - | 514.00M | 501.00M | 501.00M | 741.00M | 563.00M | 521.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | 650.00M | - | 882.00M | - | 694.00M | 664.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | 118.00M | - | 120.00M | - | 126.00M | 128.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | 375.00M | - | 620.00M | - | 428.00M | 387.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | 72.00M | - | 143.00M | - | 66.00M | 29.00M |
| Net Income | 182.00M | 182.00M | 113.00M | 141.00M | 117.00M | 143.00M | 179.00M | 137.00M | 226.00M | 209.00M | - | 300.00M | 300.00M | 477.00M | 477.00M | 362.00M | 358.00M |
| Diluted EPS | 3.66 | 3.66 | 2.27 | 2.91 | 2.47 | 3.12 | 4.02 | 3.11 | 3.83 | 3.56 | - | 5.38 | 5.38 | 8.88 | 8.88 | 7.17 | 7.70 |
| R&D Expense | 8.00M | 3.00M | 4.00M | 5.00M | 4.00M | 4.00M | 4.00M | 5.00M | 7.00M | 6.00M | 4.00M | - | 1.00M | - | 4.00M | 12.00M | 13.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jan 2011 | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Feb 2023 | Jan 2024 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.25B | 1.45B | 1.39B | 2.12B | 2.04B | 2.07B | 4.56B | 4.71B | 5.72B | - | 5.54B | 5.54B | 5.31B | 5.31B | 5.25B | 5.35B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | 1.20B | - | 1.13B | - | 1.15B | 1.18B |
| Cash & Equivalents | 1.00M | 1.00M | 1.00M | 254.00M | 301.00M | 195.00M | 210.00M | 144.00M | 237.00M | 188.00M | 171.00M | - | 109.00M | 109.00M | 94.00M | 94.00M | 56.00M | 182.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | 64.00M | 71.00M | - | 3.00M | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | 936.00M | - | 914.00M | - | 1.00B | 853.00M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | 3.84B | - | 3.53B | - | 3.67B | 3.85B |
| Current Liabilities | - | - | 638.00M | 564.00M | 552.00M | 688.00M | 623.00M | 695.00M | 897.00M | 1.13B | 1.27B | - | 1.13B | 1.13B | 1.16B | 1.16B | 1.40B | 982.00M |
| Long Term Debt | - | - | 1.00M | 489.00M | 454.00M | 1.01B | 1.02B | 983.00M | 2.06B | 1.85B | 2.45B | - | 2.34B | 2.34B | 2.02B | 2.02B | 1.91B | 2.47B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | 2.53B | - | 2.25B | - | 2.39B | 2.69B |
| Total Equity | 769.00M | 656.00M | 596.00M | 377.00M | 345.00M | 380.00M | 349.00M | 327.00M | 1.49B | 1.42B | 1.54B | - | 1.69B | 1.69B | 1.78B | 1.78B | 1.58B | 1.50B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | 54.00M | - | 52.00M | - | 48.00M | 44.00M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Feb 2023 | Jan 2024 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | 226.00M | 273.00M | 217.00M | 184.00M | 458.00M | 755.00M | - | 532.00M | 532.00M | 396.00M | 396.00M | 494.00M | 609.00M |
| Investing Cash Flow | - | - | - | - | -784.00M | -17.00M | -22.00M | -1.03B | -47.00M | -1.23B | - | -36.00M | -36.00M | 314.00M | 314.00M | -35.00M | -248.00M |
| Financing Cash Flow | - | - | - | - | 466.00M | -247.00M | -261.00M | 938.00M | -455.00M | 464.00M | - | -493.00M | -493.00M | -725.00M | -725.00M | -498.00M | -235.00M |
| Capital Expenditure | -6.00M | -7.00M | -16.00M | -22.00M | -20.00M | -15.00M | -22.00M | -28.00M | -21.00M | -46.00M | - | -25.00M | -25.00M | -27.00M | -27.00M | -36.00M | -32.00M |
| Free Cash Flow | - | - | - | - | 206.00M | 258.00M | 195.00M | 156.00M | 437.00M | 709.00M | - | 507.00M | 507.00M | 369.00M | 369.00M | 458.00M | 577.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | 3.00M | - | -15.00M | - | -39.00M | 126.00M |
| Share Buybacks | - | - | 13.00M | 149.00M | 69.00M | 180.00M | 186.00M | 69.00M | 197.00M | 34.00M | 226.00M | - | 267.00M | - | 382.00M | 558.00M | 445.00M |
| Dividends Paid | - | - | 295.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Feb 2023 | Jan 2024 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | 11.5% | - | 11.7% | - | 11.9% | 12.0% |
| Operating Margin % | 6.3% | 5.9% | 4.4% | 6.2% | 5.3% | 5.9% | 5.7% | 4.7% | 5.8% | 5.5% | - | 6.7% | 6.5% | 6.7% | 10.0% | 7.5% | 7.2% |
| Net Margin % | 3.8% | 3.8% | 2.7% | 3.6% | 2.7% | 3.2% | 4.0% | 2.9% | 3.5% | 3.0% | - | 3.9% | 3.9% | 6.4% | 6.4% | 4.8% | 4.9% |
| ROE % | 27.7% | 30.5% | 30.0% | 40.9% | 30.8% | 41.0% | 54.7% | 9.2% | 15.9% | 13.6% | - | 17.7% | 17.7% | 26.7% | 26.7% | 23.0% | 23.9% |
| ROCE % | - | 46.3% | 20.7% | 28.7% | 15.8% | 18.5% | 18.6% | 6.0% | 10.3% | 8.8% | - | 11.6% | 11.3% | 12.1% | 17.8% | 14.6% | 11.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.50% | 4.43M | $589.43M |
| 2 | Fuller & Thaler Asset Management Inc. | 5.68% | 2.96M | $393.70M |
| 3 | Vanguard Portfolio Management LLC | 4.38% | 2.28M | $303.51M |
| 4 | Vanguard Capital Management LLC | 3.74% | 1.95M | $259.18M |
| 5 | AQR Capital Management, LLC | 3.50% | 1.82M | $243.01M |
| 6 | Dimensional Fund Advisors LP | 3.27% | 1.70M | $226.56M |
| 7 | First Trust Advisors LP | 3.21% | 1.67M | $222.77M |
| 8 | Invesco Ltd. | 3.14% | 1.63M | $217.63M |
| 9 | LSV Asset Management | 3.03% | 1.58M | $210.25M |
| 10 | State Street Corporation | 2.79% | 1.45M | $193.14M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SAIC
Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough?
Science Applications International Corporation (NASDAQ:SAIC) reported second-quarter fiscal 2027 revenue of $1.88 billion, up 6.3% year over year. Net bookings, however, were approximately $1.2 billion. That produced a quarterly book-to-bil…
Science Applications International (SAIC) Stock Looks Cheap On Fair Value And Earnings
Science Applications International stock has quietly built a solid 5 year track record, yet current valuation checks suggest the market may still be pricing it below what its cash flows imply. The Discounted Cash Flow (DCF) intrinsic value …
The Bull Case For Science Applications International (SAIC) Could Change Following Mixed Q2, Guidance Hike And ORBIT Cost Push - Learn Why
In late August 2026, Science Applications International Corporation reported second-quarter fiscal 2027 results showing higher sales of US$1,880 million but lower quarterly net income of US$102 million, alongside increased full-year 2027 re…
Science Applications International Corp (SAIC) (Q2 2027) Earnings Call Highlights: Strong ...
SAIC delivers 5% organic growth and lifts FY27 outlook while navigating a shifting contracting environment.
Science Applications International Corporation Q2 2027 Earnings Call Summary
Moby summary of Science Applications International Corporation's Q2 2027 earnings call
Science Applications International Boosts Outlook as Second-Quarter Results Beat Estimates
Science Applications International (SAIC) raised its fiscal 2027 outlook on Monday as its second-qua
SAIC — Frequently Asked Questions
What is the current share price of Science Applications International Corporation (SAIC)?
As of 2026-09-19 21:16 PDT, Science Applications International Corporation (SAIC) trades at $127.55 on NasdaqGS. Its 52-week range is $81.63 to $128.96.
What is the market capitalisation of SAIC?
Science Applications International Corporation (SAIC) has a market capitalisation of $5.34B on NasdaqGS.
What is the P/E ratio of SAIC?
SAIC trades at a trailing price-to-earnings (P/E) ratio of 14.87. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 3.93.
Does SAIC pay a dividend?
Science Applications International Corporation (SAIC) currently offers a dividend yield of 1.11%.
What is the return on equity (ROE) of SAIC?
SAIC has a return on equity (ROE) of 25.74%. Its return on capital employed (ROCE) is 11.92%.
Is SAIC a good stock to buy?
This page provides a data-driven analysis of Science Applications International Corporation (SAIC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.